tetraethylammonium has been researched along with Leukemia, Basophilic, Acute in 1 studies
Tetraethylammonium: A potassium-selective ion channel blocker. (From J Gen Phys 1994;104(1):173-90)
Leukemia, Basophilic, Acute: A rare acute myeloid leukemia in which the primary differentiation is to BASOPHILS. It is characterized by an extreme increase of immature basophilic granulated cells in the bone marrow and blood. Mature basophils are usually sparse.
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 1 (100.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Gericke, M | 1 |
| Dar, O | 1 |
| Droogmans, G | 1 |
| Pecht, I | 1 |
| Nilius, B | 1 |
1 other study available for tetraethylammonium and Leukemia, Basophilic, Acute
| Article | Year |
|---|---|
Immunological stimulation of single rat basophilic leukemia RBL-2H3 cells co-activates Ca(2+)-entry and K(+)-channels.
Topics: Animals; Antigens; Barium Compounds; Calcium; Cesium; Chlorides; Dinitrophenols; Ion Transport; Leuk | 1995 |